Clinical characteristics of four children with 3M syndrome and a literature review.
10.3760/cma.j.cn511374-20220527-00357
- VernacularTitle:3M综合征患儿4例的临床特点及文献复习
- Author:
Ningan XU
1
;
Kangxiang LIU
;
Yan ZHONG
Author Information
1. Children's Health Center, Hunan Provincial Children's Hospital, Changsha, Hunan 410007, China. zhongyan@163.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Child;
Retrospective Studies;
Dwarfism/genetics*;
Muscle Hypotonia/genetics*;
Growth Hormone/therapeutic use*;
Cytoskeletal Proteins/genetics*
- From:
Chinese Journal of Medical Genetics
2023;40(7):795-801
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the clinical features of 3M syndrome and effect of growth hormone therapy.
METHODS:Clinical data of four children diagnosed with 3M syndrome by whole exome sequencing at Hunan Children's Hospital from January 2014 to February 2022 were retrospectively analyzed, which included clinical manifestation, results of genetic testing and recombinant human growth hormone (rhGH) therapy. A literature review was also carried our for Chinese patients with 3M syndrome.
RESULTS:The clinical manifestations of the 4 patients included severe growth retardation, facial dysmorphism and skeletal malformations. Two patients were found to harbor homozygous variants of CUL7 gene, namely c.4717C>T (p.R1573*) and c.967_993delinsCAGCTGG (p.S323Qfs*33). Two patients were found to harbor 3 heterozygous variants of the OBSL1 gene including c.1118G>A (p.W373*), c.458dupG (p.L154Pfs*1002) and c.690dupC (p.E231Rfs*23), among which c.967_993delinsCAGCTGG and c.1118G>A were unreported previously. Eighteen Chinese patients with 3M syndrome were identified through the literature review, including 11 cases (11/18, 61.1%) carrying CUL7 gene variants and 7 cases (7/18, 38.9%) carrying OBSL1 gene variants. The main clinical manifestations were in keeping with previously reported. Four patients were treated with growth hormone, 3 showed obvious growth acceleration, and no adverse reaction was noted.
CONCLUSION:3M syndrome has a typical appearance and obvious short stature. To attain accurate diagnosis, genetic testing should be recommended for children with a stature of less than -3 SD and facial dysmorphism. The long-term efficacy of growth hormone therapy for patients with 3M syndrome remains to be observed.
